These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7982429)

  • 1. Efficacy of L-propionylcarnitine treatment in patients with left ventricular dysfunction.
    Caponnetto S; Canale C; Masperone MA; Terracchini V; Valentini G; Brunelli C
    Eur Heart J; 1994 Sep; 15(9):1267-73. PubMed ID: 7982429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-ischaemic efficacy of L-propionylcarnitine--a promising novel metabolic approach to ischaemia?
    Bartels GL; Remme WJ; Holwerda KJ; Kruijssen DA
    Eur Heart J; 1996 Mar; 17(3):414-20. PubMed ID: 8737216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of L-propionylcarnitine on ischemia-induced myocardial dysfunction in men with angina pectoris.
    Bartels GL; Remme WJ; Pillay M; Schönfeld DH; Kruijssen DA
    Am J Cardiol; 1994 Jul; 74(2):125-30. PubMed ID: 8023775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on propionyl-L-carnitine in chronic heart failure.
    Eur Heart J; 1999 Jan; 20(1):70-6. PubMed ID: 10075143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional antiischemic effects of long-term L-propionylcarnitine in anginal patients treated with conventional antianginal therapy.
    Bartels GL; Remme WJ; den Hartog FR; Wielenga RP; Kruijssen DA
    Cardiovasc Drugs Ther; 1995 Dec; 9(6):749-53. PubMed ID: 8850378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled study on the therapeutic efficacy of propionyl-L-carnitine in patients with congestive heart failure.
    Mancini M; Rengo F; Lingetti M; Sorrentino GP; Nolfe G
    Arzneimittelforschung; 1992 Sep; 42(9):1101-4. PubMed ID: 1445476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and chronic effects of propionyl-L-carnitine on the hemodynamics, exercise capacity, and hormones in patients with congestive heart failure.
    Anand I; Chandrashekhan Y; De Giuli F; Pasini E; Mazzoletti A; Confortini R; Ferrari R
    Cardiovasc Drugs Ther; 1998 Jul; 12(3):291-9. PubMed ID: 9784909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between the effect of L-propionylcarnitine, L-acetylcarnitine and nitroglycerin in chronic peripheral arterial disease: a haemodynamic double blind echo-Doppler study.
    Sabbá C; Berardi E; Antonica G; Ferraioli G; Buonamico P; Godi L; Brevetti G; Albano O
    Eur Heart J; 1994 Oct; 15(10):1348-52. PubMed ID: 7821310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous, double-blind, cross-over study.
    Brevetti G; Perna S; Sabbà C; Rossini A; Scotto di Uccio V; Berardi E; Godi L
    Eur Heart J; 1992 Feb; 13(2):251-5. PubMed ID: 1555624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study.
    Brevetti G; Chiariello M; Ferulano G; Policicchio A; Nevola E; Rossini A; Attisano T; Ambrosio G; Siliprandi N; Angelini C
    Circulation; 1988 Apr; 77(4):767-73. PubMed ID: 3280157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of L-arginine on the Minnesota Living with Heart Failure Questionnaire quality-of-life score in patients with chronic systolic heart failure.
    Fontanive P; Saponati G; Iurato A; Volterrani C; Boni A; Piccioni L; Dini FL;
    Med Sci Monit; 2009 Dec; 15(12):CR606-11. PubMed ID: 19946230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study.
    Conraads VM; Metra M; Kamp O; De Keulenaer GW; Pieske B; Zamorano J; Vardas PE; Böhm M; Dei Cas L
    Eur J Heart Fail; 2012 Feb; 14(2):219-25. PubMed ID: 22147202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind, placebo-controlled long-term study of isosorbide-5-mononitrate therapy in patients with left ventricular dysfunction after acute myocardial infarction.
    Tingberg E; Roijer A; Thilen U; Eskilsson J; Ohlin H
    Am Heart J; 2003 Jan; 145(1):E1. PubMed ID: 12514673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction.
    Udelson JE; Feldman AM; Greenberg B; Pitt B; Mukherjee R; Solomon HA; Konstam MA
    Circ Heart Fail; 2010 May; 3(3):347-53. PubMed ID: 20299607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic therapy of congestive cardiomyopathy: effects of prenalterol and digoxin].
    Schwarz KR; Hofmann M; Mäurer W; Kadel C; von Olshausen K; Rauch B; Kübler W
    Z Kardiol; 1985 Jul; 74(7):374-83. PubMed ID: 3929486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDE 5 inhibition with udenafil improves left ventricular systolic/diastolic functions and exercise capacity in patients with chronic heart failure with reduced ejection fraction; A 12-week, randomized, double-blind, placebo-controlled trial.
    Kim KH; Kim HK; Hwang IC; Cho HJ; Je N; Kwon OM; Choi SJ; Lee SP; Kim YJ; Sohn DW
    Am Heart J; 2015 Jun; 169(6):813-822.e3. PubMed ID: 26027619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.
    Komajda M; Isnard R; Cohen-Solal A; Metra M; Pieske B; Ponikowski P; Voors AA; Dominjon F; Henon-Goburdhun C; Pannaux M; Böhm M;
    Eur J Heart Fail; 2017 Nov; 19(11):1495-1503. PubMed ID: 28462519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of propionylcarnitine on changes in endothelial function and plasma levels of adhesion molecules induced by acute exercise in patients with intermittent claudication.
    Silvestro A; Schiano V; Bucur R; Brevetti G; Scopacasa F; Chiariello M
    Angiology; 2006; 57(2):145-54. PubMed ID: 16518521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.
    Kosmala W; Holland DJ; Rojek A; Wright L; Przewlocka-Kosmala M; Marwick TH
    J Am Coll Cardiol; 2013 Oct; 62(15):1330-8. PubMed ID: 23916925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liraglutide improves cardiac function in patients with type 2 diabetes and chronic heart failure.
    Arturi F; Succurro E; Miceli S; Cloro C; Ruffo M; Maio R; Perticone M; Sesti G; Perticone F
    Endocrine; 2017 Sep; 57(3):464-473. PubMed ID: 27830456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.